[17] Romanowski B,et al.Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study. Hum Vaccin. 2011 Dec;7(12):1374-86. PMID:22048171 [18] Leung TF,et al.Comparative ...
three-dose scheduleBackground. In 2014 the Netherlands switched from 3 to 2 doses for routine vaccination with the prophylactic bivalent human papillomavirus (HPV) vaccine. The current study explored whether antibody responses are noninferior after 2 versus 3 doses in girls.Donken, RobineKlooster,...
27. Romanowski B, Schwarz TF, Ferguson LM, et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: Results from a randomized study. Human Vaccines 2011; 7(12):1374–1386. [PubMed Abstract] ...
14.Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule. 15.Romanowski, B., et al., Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent...
one or two-dose schedule for young women aged 15-20 Two doses with a 6-month interval for women older than 21. Immunocompromised individuals, including those with HIV, should receive three doses if feasible, and if not at least two doses. There is limited evidence regarding the efficacy ...
one or two-dose schedule for the primary target of girls aged 9-14 one or two-dose schedule for young women aged 15-20 Two doses with a 6-month interval for women older than 21. Immunocompromised individuals, including those with HIV, should receive three doses if feasible, and if not...
Gardasil 9 can be administered according to a 3-dose schedule: -First injection: at chosen date -Second injection: 2 months after first injection (not earlier than one month after the first dose) -Third injection: 6 months after first injection (not earlier than 3 months after the second do...
A three-dose vaccination schedule was first approved for the preventive HPV. Recent research has demonstrated that the 2 or even 1 dosage of the 2vHPV vaccination was significantly more effective than the 3-doses strategy [48]. Girls aged from 9 to 14 years who received two doses of the...
consequently, hpv vaccine uptake and completion of the 3-dose series have been suboptimal in the united states and globally, with the exception of some countries that have used school-based, opt-out vaccination programs. the potential of a reduced-dose hpv vaccine schedule to address logistical ...
Australia was one of the first countries to offer a national, publicly funded vaccination program, using a three-dose schedule of the quadrivalent vaccine Gardasil©. Commencing in April 2007, the Australian vaccination program targeted 12- and 13-year-old girls in schools and offered catch-up ...